Recurrence of Focal Segmental Glomerulosclerosis after Renal Transplantation:Three Cases Report

Zhihong Liu
2010-01-01
Abstract:Objective:In this report,we evaluated the clinical and histopathological characteristics and sequelae of posttransplant recurrent focal segmental glomerulosclerosis(FSGS). Methodology:A retrospective analysis was carried out in three posttransplant recurrent FSGS patients.The renal biopsy of native,donor and allograft were performed to evaluated histopathologic features.The clinical and laboratory data,and response to treatment were recorded in detail. Results:(1)There were one male and two females.Their onset ages were 17,23,and 40 yrs.The levels of 24h urinary proteinuria excretion as native renal biopsy were 7.55,10.5 and 14.26 g/24h.The levels of serum creatinine were 99,105.2 and 265.2 μmol/L.The time of progression to ESRD were 4,2 and 4yrs,respectively.(2)Proportion of glomerular/segmental sclerosing lesions were 5.30%/42.1%,0/6.90% and 40%/33.3%,acute/chronic tubulointerstitial lesion were 0/10%,10%/0 and 10%/30%.We observed the diffuse foot process effacement(50%) by electron microscopy in case 2 and 3 of native renal biopsy,while no tissue for TEM in case 3.FSGS variants in native kidneys were cellular,tip lesion,and cellular type,respectively.(3)Proteinuria occurred at 10 and 40 days after transplantation in case 1 and 2(18.3 and 7.55g/24h),3 cases were diagnozed recurrent FSGS at 130,67 and 70 days after transplantation.The levels of 24h urinary proteinuria excretion were 10.1,15.8,and 4.38g/24h.The levels of serum creatinine were 114.0 μmol/L,484.4 μmol/L and 701.8 μmol/L..(4) Early graft biopsies might show normal appearing glomeruli by light microscopy but diffuse foot process effacement by electron microscopy.Segmental sclerosing lesions may occur later in repeated renal biopsy,with acute tubulointerstitial lesion;FSGS variants in graft kidneys are cellular,collapsing,cellular,respectively.(5) Case 1 was treated with 5 cycles of plasmapheresis,and achieved a partial remission;case 2 was received with 5 cycles of immunoadsorption,achieved no remission,and progressed to ESRD at 3 months after transplantation.Case 3 lost follow-up. Conclusion:Proteinuria and renal dysfunction were noticeable clinical manifestations in recurrent FSGS after renal transplantation.In patients with recurrent proteinuria,early graft biopsies may be normal appearing glomeruli by light microscopy,but diffuse foot process effacement by electron microscopy,and segmental sclerosing lesions in repeat biopsy later.FSGS variants in graft kidneys may be same with or different from native kidney.
What problem does this paper attempt to address?